Interaction databaseSupplement × PrescriptionReviewed May 2026

Enoxaparin and Nattokinase, a caution.

Nattokinase has fibrinolytic activity and can reduce clotting factor levels. Enoxaparin potentiates antithrombin activity against factor Xa, so the combination may substantially weaken clotting through separate mechanisms. The risk is highest after surgery, with kidney impairment, or when other antiplatelet or anticoagulant drugs are present.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Enoxaparin and Nattokinase
Pair type
Caution
Evidence (highest tier)
Emerging
Source citations
2 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Emerging evidence

Caution

What is happening. Nattokinase has fibrinolytic activity and can reduce clotting factor levels. Enoxaparin potentiates antithrombin activity against factor Xa, so the combination may substantially weaken clotting through separate mechanisms. The risk is highest after surgery, with kidney impairment, or when other antiplatelet or anticoagulant drugs are present.

Mechanism. Nattokinase directly degrades fibrin and lowers fibrinogen, factor VII, and factor VIII. Enoxaparin enhances antithrombin-mediated factor Xa inhibition, so combined use affects both fibrin formation and fibrin breakdown.

Recommendation. Avoid nattokinase while using enoxaparin. If the combination has already been used, stop nattokinase and watch for bruising, nosebleeds, black stools, blood in urine, severe headache, or sudden weakness.

Sources (2)
  1. Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-469. PMID 18310985
  2. Hsia CH, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res. 2009;29(3):190-196. PMID 19358933

Stack Score

How this pair moves the number.

Effect on the composite score

If both Enoxaparin and Nattokinase are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.